Frequency of defecation (mean number of bowel movements per week) · children with chronic constipation without a physical explanation
1 finding from 1 review
Global assessment of treatment success · children with chronic constipation without a physical explanation
Probiotics and osmotic laxative showed no clear difference in global improvement or treatment success, as defined by primary studies compared with osmotic laxative (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · children with chronic constipation without a physical explanation
It is very uncertain whether probiotics and osmotic laxative changes withdrawal due to adverse events compared with osmotic laxative (very low certainty).
1 finding from 1 review
Serious adverse events · children with chronic constipation without a physical explanation
1 finding from 1 review
Major clinical improvement at six months · Patients with pelvic floor dyssynergia and chronic constipation
EMG biofeedback may leads to higher major clinical improvement at six months compared with laxative (low certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
S uccessful disimpaction · patients aged 0 to 18 years with a diagnosis of functional constipation
PEG showed no clear difference in S uccessful disimpaction compared with enema (low certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Need for extra treatment · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether PEG changes need for additional therapies compared with flixweed (very low certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Need for extra treatment · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether PEG changes need for additional therapies compared with dietary fibre (very low certainty).
1 finding from 1 review
Frequency of faecal incontinence · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Need for extra treatment · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether high dose PEG changes need for additional therapy compared with low dose PEG (very low certainty).
1 finding from 1 review
Serious adverse events · patients aged 0 to 18 years with a diagnosis of functional constipation
PEG showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Faecal incontinence · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether high dose PEG changes faecal incontinence compared with low dose PEG (very low certainty).
1 finding from 1 review
Adverse events · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether high dose PEG changes adverse events compared with low dose PEG (very low certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review